journal article·2024-09Open access

Blood Brain Barrier‐Crossing Delivery of Felodipine Nanodrug Ameliorates Anxiety‐Like Behavior and Cognitive Impairment in Alzheimer's Disease

Xiaofei He, Yuan Peng, Sicong Huang, Zecong Xiao, Ge Li, Zejie Zuo, Liying Zhang, Xintao Shuai, Haiqing Zheng, Xiquan Hu

Advanced Science· Volume 11· Issue 34

Abstract

Abstract Alzheimer's disease (AD) is the most common age‐related neurodegenerative disorder leading to cognitive decline. Excessive cytosolic calcium (Ca2+) accumulation plays a critical role in the pathogenesis of AD since it activates the NOD‐like receptor family, pyrin domain containing 3 (NLRP3), switches the endoplasmic reticulum (ER) unfolded protein response (UPR) toward proapoptotic signaling and promotes Aβ seeding. Herein, a liposomal nanodrug (felodipine@LND) is developed incorporating a calcium channel antagonist felodipine for Alzheimer's disease treatment through a low‐intensity pulse ultrasound (LIPUS) irradiation‐assisted blood brain barrier (BBB)‐crossing drug delivery. The multifunctional felodipine@LND is effectively delivered to diseased brain through applying a LIPUS irradiation to the skull, which resulted in a series of positive effects against AD. Markedly, the nanodrug treatment switched the ER UPR toward antioxidant signaling, prevented the surface translocation of ER calreticulin (CALR) in microglia, and inhibited the NLRP3 activation and Aβ seeding. In addition, it promoted the degradation of damaged mitochondria via mitophagy, thereby inhibiting the neuronal apoptosis. Therefore, the anxiety‐like behavior and cognitive impairment of 5xFAD mice with AD is significantly ameliorated, which manifested the potential of LIPUS – assisted BBB‐crossing delivery of felodipine@LND to serve as a paradigm for AD therapy based on the well‐recognized clinically available felodipine.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Endoplasmic Reticulum Stress and Disease · Vagus Nerve Stimulation Research · Ultrasound and Hyperthermia Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Rehabilitation Medicine The Third Affiliated Hospital Sun Yat‐sen University 600 Tianhe Road Guangzhou Guangdong 510630 China

Department of Rehabilitation Medicine Guangzhou First People's Hospital Guangzhou 510180 China

School of Materials Science and Engineering Sun Yat‐sen University Guangzhou 510275 China

Nanomedicine Research Center The Third Affiliated Hospital of Sun Yat‐sen University Guangzhou 510630 China

Guangdong Provincial Key Laboratory of Laboratory Animals Guangdong Laboratory Animals Monitoring Institute 11 Fengxin Road Guangzhou Guangdong 510663 China

Funding

National Key Research and Development Program of China · National Natural Science Foundation of China

References (60)

Show source-provided references
1. 10.1016/S0140-6736(20)32205-410.1016/S0140-6736(20)32205-4 ↗
2. 10.1126/sciadv.abc703110.1126/sciadv.abc7031 ↗
3. 10.1002/bmm2.1201110.1002/bmm2.12011 ↗
4. 10.1002/EXP.2023002910.1002/EXP.20230029 ↗
5. 10.1038/s41467-024-45656-710.1038/s41467-024-45656-7 ↗
6. 10.1016/j.arr.2021.10150310.1016/j.arr.2021.101503 ↗
7. 10.1016/j.cmet.2019.06.00510.1016/j.cmet.2019.06.005 ↗
8. 10.1016/j.cell.2019.05.05610.1016/j.cell.2019.05.056 ↗
9. 10.1016/j.cell.2019.09.00110.1016/j.cell.2019.09.001 ↗
10. 10.1038/s41590-021-00913-510.1038/s41590-021-00913-5 ↗
11. 10.1002/glia.2307410.1002/glia.23074 ↗
12. 10.1016/j.celrep.2020.02.02510.1016/j.celrep.2020.02.025 ↗
13. 10.1038/s41418-018-0195-310.1038/s41418-018-0195-3 ↗
14. 10.1038/s41577-019-0167-y10.1038/s41577-019-0167-y ↗
15. 10.1038/nature2514310.1038/nature25143 ↗
16. 10.1126/sciadv.abe360010.1126/sciadv.abe3600 ↗
17. 10.1523/JNEUROSCI.0617-19.201910.1523/JNEUROSCI.0617-19.2019 ↗
18. 10.1016/j.immuni.2020.03.00410.1016/j.immuni.2020.03.004 ↗
19. 10.1055/s-2000-817910.1055/s-2000-8179 ↗
20. 10.2174/157488631066615051411461910.2174/1574886310666150514114619 ↗
21. 10.1038/s41467-019-09494-210.1038/s41467-019-09494-2 ↗
22. 10.3109/15563650.2014.96582710.3109/15563650.2014.965827 ↗
23. 10.1097/00005344-199015004-0002610.1097/00005344-199015004-00026 ↗
24. 10.1016/j.biomaterials.2018.06.02410.1016/j.biomaterials.2018.06.024 ↗
25. 10.3390/nano1213214010.3390/nano12132140 ↗
26. 10.1002/bmm2.1201810.1002/bmm2.12018 ↗
27. 10.1016/j.jconrel.2022.05.04210.1016/j.jconrel.2022.05.042 ↗
28. 10.1007/s11060-019-03204-010.1007/s11060-019-03204-0 ↗
29. 10.1016/j.neuron.2020.09.00310.1016/j.neuron.2020.09.003 ↗
30. 10.1126/scitranslmed.aaf608610.1126/scitranslmed.aaf6086 ↗
31. 10.1056/NEJMoa230871910.1056/NEJMoa2308719 ↗
32. Kraeuter A. · 2019 · 99
33. 10.1016/j.ccell.2023.04.01510.1016/j.ccell.2023.04.015 ↗
34. 10.1038/s41467-023-39172-310.1038/s41467-023-39172-3 ↗
35. 10.1016/j.arr.2018.07.00410.1016/j.arr.2018.07.004 ↗
36. 10.1038/nrc338010.1038/nrc3380 ↗
37. 10.1016/j.bbi.2017.11.01810.1016/j.bbi.2017.11.018 ↗
38. 10.1080/15548627.2020.184079610.1080/15548627.2020.1840796 ↗
39. 10.1038/ni.163610.1038/ni.1636 ↗
40. 10.2174/156720501666619121009130210.2174/1567205016666191210091302 ↗
41. 10.1126/science.aao604710.1126/science.aao6047 ↗
42. 10.1038/s41586-023-06373-110.1038/s41586-023-06373-1 ↗
43. 10.1523/JNEUROSCI.0679-22.202210.1523/JNEUROSCI.0679-22.2022 ↗
44. 10.1038/s41593-018-0332-910.1038/s41593-018-0332-9 ↗
45. 10.1038/cdd.2017.4410.1038/cdd.2017.44 ↗
46. 10.1177/0271678X1560820110.1177/0271678X15608201 ↗
47. 10.1126/sciadv.adg661810.1126/sciadv.adg6618 ↗
48. 10.18632/oncotarget.597810.18632/oncotarget.5978 ↗
49. 10.1002/bmm2.1201010.1002/bmm2.12010 ↗
50. 10.1016/j.bioadv.2022.21310210.1016/j.bioadv.2022.213102 ↗
51. 10.1161/STROKEAHA.123.04300510.1161/STROKEAHA.123.043005 ↗
52. 10.1007/978-1-60327-360-2_1310.1007/978-1-60327-360-2_13 ↗
53. 10.1186/s40035-022-00292-310.1186/s40035-022-00292-3 ↗
54. 10.2217/nnm.13.20410.2217/nnm.13.204 ↗
55. 10.1016/j.biomaterials.2018.05.01910.1016/j.biomaterials.2018.05.019 ↗
56. Shen Y. · Biomed. Mater. Eng. · 2014 · 24 · 2831
57. 10.1111/jnc.1365710.1111/jnc.13657 ↗
58. 10.1007/s10339-011-0430-z10.1007/s10339-011-0430-z ↗
59. 10.1038/nprot.2006.11610.1038/nprot.2006.116 ↗
60. 10.3390/ijms23211360610.3390/ijms232113606 ↗